Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A human abuse potential study of oral Rexista

Trial Profile

A human abuse potential study of oral Rexista

Recruiting
Phase of Trial: Phase II

Latest Information Update: 10 Oct 2018

At a glance

  • Drugs Oxycodone (Primary)
  • Indications Pain
  • Focus Registrational; Therapeutic Use
  • Sponsors Intellipharmaceutics International
  • Most Recent Events

    • 10 Oct 2018 According to an Intellipharmaceutics International clinical component of study has been completed. Bioanalytical samples and statistical analysis for such studies are pending. An update on the results will be provided once the analysis is complete.
    • 16 Jul 2018 Status changed from planning to recruiting, as reported in the Intellipharmaceutics media release.
    • 16 Jul 2018 According to a an Intellipharmaceutics media release, this trial is underway.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top